Search Results

Thrombin and PAR1-activating peptide: Effects on human uterine contractility in vitro.

• Authors : O'Sullivan, Crochan J.; Allen, Nicholas M.; O'Loughlin, Aonghus J.

Subjects: THROMBIN; UTERINE contraction; HEMOSTATICS

• Source: American Journal of Obstetrics & Gynecology. Apr2004, Vol. 190 Issue 4, p1098-1105. 8p. 2 Charts, 9 Graphs.

Record details

High-resolution crystal structure of human protease-activated receptor 1.

• Authors : Zhang, Cheng; Srinivasan, Yoga; Arlow, Daniel H.

Subjects: PROTEASE-activated receptors; CRYSTAL structure; THROMBIN

• Source: Nature. 12/20/2012, Vol. 492 Issue 7429, p387-392. 6p. 4 Diagrams, 1 Graph.

Record details

Low concentrations of thrombin-inhibitor complexes and the risk of preterm delivery

• Authors : Hackney, David N.; Catov, Janet M.; Simhan, Hyagriv N.

Subjects: RISK factors in premature labor; ANTITHROMBINS; THROMBIN

• Source: American Journal of Obstetrics & Gynecology. Aug2010, Vol. 203 Issue 2, p184.e1-184.e6. 0p.

Record details

Intraoperative Intratumoral Injection of Gelatin–Thrombin Matrix (III-GTHM) for Carotid Body Tumour Excision.

• Authors : Binnetoglu, Adem; Demir, Berat; Gundogdu, Yavuz

Subjects: INJECTIONS; CAROTID body; INTRAOPERATIVE careTURKEY

• Source: ENT: Ear, Nose & Throat Journal. Feb2022, Vol. 101 Issue 2, pNP78-NP79. 2p.

Record details

Dabigatran: A new orally available anticoagulant for prevention of strokes and thrombosis in patients with atrial fibrillation.

• Authors : Talati, Ripple (AUTHOR); White, C. Michael (AUTHOR)

Subjects: CEREBROVASCULAR disease prevention; THROMBOSIS prevention; ANTICOAGULANTS

• Source: Formulary. Feb2011, Vol. 46 Issue 2, p44-53. 6p. 1 Chart.

Record details

Outcomes of Geriatric Trauma Patients on Preinjury Anticoagulation: A Multicenter Study.

• Authors : ANG, DARWIN; KUREK, STAN; MCKENNEY, MARK

Subjects: ANTICOAGULANTS; TRAUMA centers; TRAUMATIC shock (Pathology)FLORIDA

• Source: American Surgeon. Jun2017, Vol. 83 Issue 6, p527-535. 9p.

Record details

Misadministration of topical bovine thrombin.

• Authors : Gershon, S K (AUTHOR); Chang, A C (AUTHOR); Purvis, W V (AUTHOR)

Subjects: DISEASE complications; DRUG labeling; DRUG side effects

• Source: JAMA: Journal of the American Medical Association. 11/24/99, Vol. 282 Issue 20, p1919-1919. 1p.

Record details

In an in-vitro model using human fetal membranes, 17-α hydroxyprogesterone caproate is not an optimal progestogen for inhibition of fetal membrane weakening.

• Authors : Kumar, Deepak; Moore, Robert M.; Mercer, Brian M.

Subjects: PREMATURE labor prevention; FETAL membranes; HYDROXYPROGESTERONE

• Source: American Journal of Obstetrics & Gynecology. Dec2017, Vol. 217 Issue 6, p695.e1-695.e14. 1p.

Record details

Clinical studies review findings on triple-antiplatelet therapy after PCI, investigational thrombin receptor antagonist.

• Authors : Kuznar, Wayne (AUTHOR)

Subjects: THROMBOSIS prevention; WARFARIN; DRUG therapyILLINOIS

• Source: Formulary. May2012, Vol. 47 Issue 5, p184-196. 9p. 1 Color Photograph, 2 Charts, 1 Graph.

Record details

Dabigatran may be a cost-effective alternative to warfarin for stroke prevention in atrial fibrillation.

Subjects: CEREBROVASCULAR disease prevention; DRUG therapy; WARFARIN

• Source: Formulary. Feb2011, Vol. 46 Issue 2, p39-39. 1/2p.

Record details